Icagen Revenue and Competitors
Estimated Revenue & Valuation
- Icagen's estimated annual revenue is currently $3.7M per year.
- Icagen's estimated revenue per employee is $77,500
- Icagen's total funding is $29.5M.
Employee Data
- Icagen has 48 Employees.
- Icagen grew their employee count by -19% last year.
Icagen's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP Research | Reveal Email/Phone |
3 | Senior Principal Scientist | Reveal Email/Phone |
4 | Scientist | Reveal Email/Phone |
5 | Principal Investigator | Reveal Email/Phone |
6 | Associate Research Fellow | Reveal Email/Phone |
7 | Senior Scientist - Electrophysiologist | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | Scientist | Reveal Email/Phone |
10 | Principal Research Investigator | Reveal Email/Phone |
Icagen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $0.8M | 5 | -29% | N/A | N/A |
#4 | $5.3M | 34 | 0% | N/A | N/A |
#5 | $2.5M | 16 | -20% | N/A | N/A |
#6 | $1.1M | 7 | 0% | N/A | N/A |
#7 | $0.9M | 6 | 0% | N/A | N/A |
#8 | $2.2M | 29 | 21% | $58.2M | N/A |
#9 | $171.9M | 1109 | -3% | N/A | N/A |
#10 | $0.9M | 6 | 0% | N/A | N/A |
What Is Icagen?
Icagen, Inc., a privately-held company based in Research Triangle Park, North Carolina, is a leader in drug discovery and development focused exclusively on ion channel modulation. Icagen maintains proprietary biological targets, screening methods and gene family chemical libraries, and has ongoing discovery and development programs in cardiovascular, central nervous system, urology, hematology, and immunology disorders.
keywords:N/A$29.5M
Total Funding
48
Number of Employees
$3.7M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Icagen News
Teva Pharmaceutical Industries Ltd, Xenon, Biogen, ICAGEN, INC, Pfizer Inc, Zydus Cadila, ANI Pharmaceuticals, Inc, Novel Laboratories Inc, Norvartis AG,...
... include Brooks Automation, Hamilton Company, TTP Group, Labcyte, Biosero, Tecan, Evotec, Wuxi AppTec, Icagen, and TCG Lifescience.
Drug development company Icagen Inc. raised $7.25 million from one investor, according to a filing with the Securities and Exchange Commission. The Durham-based company filed a Form D to report the offering and disclosed that the funds will be used to pay overhead and other corporate expenses, ...
Icagen Inc., a pharmaceutical development company, has raised $2 million, according to a filing with the Securities and Exchange Commission. The money was raised in the form of equity and options from one investor, according to the filing. The company still has $2 million left to raise. Icagen ...
Icagen Inc., a Durham-based drug discovery company, sold $1.5 million in shares in a private offering, according to a Securities and Exchange Commission filing. Icagen filed the Form D on April 27. The company stated that the proceeds may be used to pay overhead and other corporate expenses, wh ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.8M | 50 | 6% | N/A |
#2 | $3.5M | 69 | 1% | N/A |
#3 | $13.7M | 76 | 41% | N/A |
#4 | $21.3M | 84 | 14% | N/A |
#5 | $23.9M | 97 | 1% | N/A |